| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 |
| filingDate |
2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6720b1f0852b08ea8f3ca76148ec64b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1254b387e1f3f5536de6faed98f02fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91536f8c3d16cd2316c0f7ccceae57f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9128df3ecb5064cc62126e4f9b16da1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_494ec14a8b90baced57e49ed5db4a015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26bd93251cfc5ac5a578d5849529849d |
| publicationDate |
2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017327490-A1 |
| titleOfInvention |
Piperidine isoxazole and isothiazole orexin receptor antagonists |
| abstract |
The present invention is directed to piperidine isoxazole and isothiazole orexin compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the prevention or treatment of such diseases in which orexin receptors are involved. |
| priorityDate |
2014-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |